Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Achim Rody

Showing results (81-90 of 202) with videos related to

Pageof 21
Sort By:
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|March 23, 2013
Acid ceramidase (AC)--a key enzyme of sphingolipid metabolism--correlates with better prognosis in epithelial ovarian cancerLars Christian Hanker, Thomas Karn, Uwe Holtrich, et al.
The Breast Journal|April 12, 2014
Estrogen, progesterone, and Her-2/neu receptor expression discrepancy in primary tumors and in-breast relapse in patients with breast cancerRussalina Mavrova, Julia Radosa, Kai Schmitt, et al.
In Vivo (Athens, Greece)|November 16, 2014
Does maternal underweight prior to conception influence pregnancy risks and outcome?Friederike Hoellen, Amadeus Hornemann, Christoph Haertel, et al.
In Vivo (Athens, Greece)|April 30, 2024
ARID1 and BRG1 Expression in Endometrial CancerEmmanuel N Kontomanolis, Panagiotis Symeonidis, Konstantinos Nikolettos, et al.
Oncology Reports|September 18, 2004
Estrogen receptor alpha and beta, progesterone receptor, pS2 and HER-2/neu expression delineate different subgroups in ductal carcinoma in situ of the breastAchim Rody, Raihanatou Diallo, Christopher Poremba, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 2, 2023
Calcium electroporation in cutaneous metastases - A non-randomised phase II multicentre clinical trialMille Vissing, Mascha Pervan, John Pløen, et al.
Molecular and Clinical Oncology|October 5, 2016
Trefoil factor 3 expression in epithelial ovarian cancer exerts a minor effect on clinicopathological parametersFriederike Hoellen, Athina Kostara, Thomas Karn, et al.
Anticancer Research|January 29, 2018
Effects of Combined Treatment with Vitamin D and COX2 Inhibitors on Breast Cancer Cell LinesMichael Friedrich, Kathrin Reichert, Alena Woeste, et al.
Journal of Medical Internet Research|August 12, 2021
The Effect of Collaborative Reviews of Electronic Patient-Reported Outcomes on the Congruence of Patient- and Clinician-Reported Toxicity in Cancer Patients Receiving Systemic Therapy: Prospective, Multicenter, Observational Clinical TrialAndreas Trojan, Nicolas Leuthold, Christoph Thomssen, et al.
Anticancer Research|July 5, 2020
Resumption of Trastuzumab in Patients With Disease Recurrence After (Neo-) Adjuvant Anti-HER2-therapy in Patients With HER2-positive Breast CancerLars Christian Hanker, Frank FÖrster, Jan SchrÖder, et al.
Pageof 21

Showing results (81-90 of 202) with videos related to

Sort By:
Pageof 21
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|March 23, 2013
Acid ceramidase (AC)--a key enzyme of sphingolipid metabolism--correlates with better prognosis in epithelial ovarian cancerLars Christian Hanker, Thomas Karn, Uwe Holtrich, et al.
The Breast Journal|April 12, 2014
Estrogen, progesterone, and Her-2/neu receptor expression discrepancy in primary tumors and in-breast relapse in patients with breast cancerRussalina Mavrova, Julia Radosa, Kai Schmitt, et al.
In Vivo (Athens, Greece)|November 16, 2014
Does maternal underweight prior to conception influence pregnancy risks and outcome?Friederike Hoellen, Amadeus Hornemann, Christoph Haertel, et al.
In Vivo (Athens, Greece)|April 30, 2024
ARID1 and BRG1 Expression in Endometrial CancerEmmanuel N Kontomanolis, Panagiotis Symeonidis, Konstantinos Nikolettos, et al.
Oncology Reports|September 18, 2004
Estrogen receptor alpha and beta, progesterone receptor, pS2 and HER-2/neu expression delineate different subgroups in ductal carcinoma in situ of the breastAchim Rody, Raihanatou Diallo, Christopher Poremba, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 2, 2023
Calcium electroporation in cutaneous metastases - A non-randomised phase II multicentre clinical trialMille Vissing, Mascha Pervan, John Pløen, et al.
Molecular and Clinical Oncology|October 5, 2016
Trefoil factor 3 expression in epithelial ovarian cancer exerts a minor effect on clinicopathological parametersFriederike Hoellen, Athina Kostara, Thomas Karn, et al.
Anticancer Research|January 29, 2018
Effects of Combined Treatment with Vitamin D and COX2 Inhibitors on Breast Cancer Cell LinesMichael Friedrich, Kathrin Reichert, Alena Woeste, et al.
Journal of Medical Internet Research|August 12, 2021
The Effect of Collaborative Reviews of Electronic Patient-Reported Outcomes on the Congruence of Patient- and Clinician-Reported Toxicity in Cancer Patients Receiving Systemic Therapy: Prospective, Multicenter, Observational Clinical TrialAndreas Trojan, Nicolas Leuthold, Christoph Thomssen, et al.
Anticancer Research|July 5, 2020
Resumption of Trastuzumab in Patients With Disease Recurrence After (Neo-) Adjuvant Anti-HER2-therapy in Patients With HER2-positive Breast CancerLars Christian Hanker, Frank FÖrster, Jan SchrÖder, et al.
Pageof 21